Filing metadata

Accession number
0000899243-21-002033
Form type
Form 3
Filer
Checkmate Pharmaceuticals, Inc.
CIK
CIK 1651431
Filed
Jan 14, 2021
Reporting period
Jan 04, 2021
Description
Initial ownership

Explore SEC Filings Hub